BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2780041)

  • 41. Serum thyroglobulin as a risk factor for thyroid carcinoma.
    Hrafnkelsson J; Tulinius H; Kjeld M; Sigvaldason H; Jónasson JG
    Acta Oncol; 2000; 39(8):973-7. PubMed ID: 11207005
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is there a "difference" in thyroglobulin testing.
    Levy EG
    Thyroid; 2000 Feb; 10(2):193-4. PubMed ID: 10718559
    [No Abstract]   [Full Text] [Related]  

  • 43. [Thyroglobulin as a tumor marker in thyroid adenocarcinoma--its effectiveness and problems in monitoring cancer activities].
    Aoki N; Nagata I; DeGroot LJ
    Nihon Gan Chiryo Gakkai Shi; 1983 Apr; 18(3):673-81. PubMed ID: 6619633
    [No Abstract]   [Full Text] [Related]  

  • 44. Malignant follicles of a differentiated thyroid carcinoma releasing iodinated thyroglobulin into the lymphatic vessels.
    Gebel F; Studer H
    Clin Endocrinol (Oxf); 1984 Apr; 20(4):457-62. PubMed ID: 6713694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum thyroglobulin in the management of thyroid cancer.
    Blahd WH
    J Nucl Med; 1990 Nov; 31(11):1771-3. PubMed ID: 2121914
    [No Abstract]   [Full Text] [Related]  

  • 46. Optimal management of a biochemical incomplete response to therapy in differentiated thyroid cancer: aggressive treatment or cautious observation?
    Tuttle RM
    Endocrine; 2014 Aug; 46(3):363-4. PubMed ID: 24615658
    [No Abstract]   [Full Text] [Related]  

  • 47. Serum ferritin in thyroid cancer.
    Deshpande UR; Nadkarni GD; Samuel AM
    Thyroid; 1993; 3(4):301-3. PubMed ID: 8118224
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Serum thyroglobulin in thyroid neoplasms].
    Mimura T; Ishikawa N; Hasegawa M; Manabe Y; Momotani S
    Horumon To Rinsho; 1983 Aug; 31(8):731-5. PubMed ID: 6627707
    [No Abstract]   [Full Text] [Related]  

  • 49. Mixed follicular-parafollicular carcinoma of the thyroid.
    Burt AD; MacGuire J; Lindop GB; Browne MK
    Scott Med J; 1987 Apr; 32(2):50-1. PubMed ID: 3602988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.
    Fatemi S; LoPresti JS
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4507-8; author reply 4508-10. PubMed ID: 12970333
    [No Abstract]   [Full Text] [Related]  

  • 51. [Usefulness of blood thyroglobulin determination in patients with thyroid cancer].
    Ikekubo K; Hamasaki T; Yamada A; Bito S; Tochio H; Saiki Y; Ito H; Morimoto Y; Akamizu T; Sawada K
    Kaku Igaku; 1983 Apr; 20(3):313-9. PubMed ID: 6632358
    [No Abstract]   [Full Text] [Related]  

  • 52. Serum thyroglobulin levels in patients with bone metastases from an unknown primary site.
    Shah DH; Krishna BA; Pradhan SA; Rao RS; Ganatra RD; Sharma SM
    Tumori; 1982 Dec; 68(6):481-3. PubMed ID: 7168013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retrospective Analysis of Thyroid Cancer Patients.
    Anand SS; Sood V; Kumar PG; Sinha I; Kotwal A
    Med J Armed Forces India; 2008 Jan; 64(1):7-10. PubMed ID: 27408070
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intrahepatic cholangiocarcinoma resembling a thyroid follicular neoplasm.
    Fornelli A; Bondi A; Jovine E; Eusebi V
    Virchows Arch; 2010 Mar; 456(3):339-42. PubMed ID: 20082203
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unusual mesentery metastasis of differentiated thyroid cancer: a case report.
    Chwa S; Lee SH; Lee SH
    Korean J Clin Oncol; 2023 Dec; 19(2):84-87. PubMed ID: 38229494
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Follow up of thyroglobulin levels in patients with surgically treated, highly differentiated thyroid cancer].
    Szántó J; Vincze B; Sinkovits I; Karika Z; Daubner K; Péter I; Kazatsay I; Eckhardt S
    Orv Hetil; 1989 Aug; 130(32):1695-9. PubMed ID: 2780041
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postoperative thyroglobulin level determination to follow up patients with highly differentiated thyroid cancer.
    Szántó J; Vincze B; Sinkovics I; Karika Z; Daubner K; Péter I; Kazatsay I; Eckhardt S
    Oncology; 1989; 46(2):99-104. PubMed ID: 2710483
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas.
    Lin JD; Huang MJ; Hsu BR; Chao TC; Hsueh C; Liu FH; Liou MJ; Weng HF
    J Surg Oncol; 2002 May; 80(1):45-51. PubMed ID: 11967907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
    Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
    Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of estimation of the ratio of preoperative serum thyroglobulin to the thyroid mass in predicting the behaviour of well differentiated thyroid cancers.
    Sharma AK; Sarda AK; Chattopadhyay TK; Kapur MM
    J Postgrad Med; 1996; 42(2):39-42. PubMed ID: 9715297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.